ArticleTargeted oncology2024

Impact of PD-L1 Expression on the Overall Survival of Caucasian Patients with Advanced EGFR-Mutant NSCLC Treated with Frontline Osimertinib.

Thomas Papazyan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.